相关实验视频

Updated: Jul 23, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

前列腺癌放射性药物治疗的临床前发展

Suresh Alati¹, Rajan Singh¹, Martin G Pomper¹

¹Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

Seminars in nuclear medicine

|July 19, 2023

概括

放射性药物治疗为前列腺癌治疗提供了一种有针对性的方法. 目前的研究重点是优化治疗放射性核素和瘤向剂,以提高疗效和降低毒性.

科学领域:

在瘤学瘤学.
放射性药物科学放射性药物科学
医学物理医学物理

背景情况:

前列腺癌是全球男性癌症死亡的重要原因之一.
放射性药物疗法通过直接向瘤输送辐射来提供全身治疗.
主要目标包括前列腺特异性膜抗原 (PSMA),人类卡利克林酶和其他过度表达的受体.

研究的目的:

审查前列腺癌临床前期放射性药物治疗的最新进展.
总结治疗放射性核素和瘤向策略的进展.

主要方法:

对α,β和Auger电子发射放射性核酸的研究.
开发向分子,包括单克隆抗体,抗体碎片,和小分子.
结构-活性关系研究,以提高安全性和有效性.

主要成果:

随着最近的监管批准,Lu-PSMA-617代表了一项重大进步.
目前正在进行的研究探讨了新型放射性核酸 (例如,211At,225Ac) 和精制的向剂.
组合疗法正在成为一个有前途的战略.

结论:

放射性药物治疗,特别是针对PSMA的药物,对前列腺癌有很大的前景.
对放射性核素和向分子优化的持续研究对于改善患者的治疗结果至关重要.
未来的方向包括结构修改,以提高瘤向性和减少毒性.

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

相关概念视频

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...